Ikumi Kasahara

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.

Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.

Journal: International journal of hematology

Published: November 07, 2025

Morphea-like subcutaneous panniculitis-like T-cell lymphoma.

Morphea-like subcutaneous panniculitis-like T-cell lymphoma.

Journal: JAAD case reports

Published: March 21, 2024

Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.

Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.

Journal: Haematologica

Published: December 09, 2023

Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.

Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.

Journal: British journal of haematology

Published: August 09, 2023

Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.

Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.

Journal: European journal of haematology

Published: April 30, 2023

Refractory Erdheim-Chester disease with central nervous system lesion complicated by central diabetes insipidus

Refractory Erdheim-Chester disease with central nervous system lesion complicated by central diabetes insipidus

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 09, 2020

Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.

Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.

Journal: Hematological oncology

Published: April 23, 2020

A role for IL-34 in osteolytic disease of multiple myeloma.

A role for IL-34 in osteolytic disease of multiple myeloma.

Journal: Blood advances

Published: April 23, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026